<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Bioeng. Biotechnol.</journal-id>
<journal-title>Frontiers in Bioengineering and Biotechnology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Bioeng. Biotechnol.</abbrev-journal-title>
<issn pub-type="epub">2296-4185</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1149588</article-id>
<article-id pub-id-type="doi">10.3389/fbioe.2023.1149588</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Bioengineering and Biotechnology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Antimicrobial, anticancer, and biofilm inhibition studies of highly reduced graphene oxide (HRG): <italic>In vitro</italic> and <italic>in silico</italic> analysis</article-title>
<alt-title alt-title-type="left-running-head">Alangari et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fbioe.2023.1149588">10.3389/fbioe.2023.1149588</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Alangari</surname>
<given-names>Abdulaziz</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2181802/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mateen</surname>
<given-names>Ayesha</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alqahtani</surname>
<given-names>Mohammed S.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1110643/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shahid</surname>
<given-names>Mudassar</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1132558/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Syed</surname>
<given-names>Rabbani</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/932725/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shaik</surname>
<given-names>Mohammed Rafi</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1672266/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Khan</surname>
<given-names>Mujeeb</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1499455/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Adil</surname>
<given-names>Syed Farooq</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1191525/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kuniyil</surname>
<given-names>Mufsir</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1672134/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Clinical Laboratory Sciences</institution>, <institution>College of Applied Medical Sciences</institution>, <institution>King Saud University</institution>, <addr-line>Riyadh</addr-line>, <country>Saudi Arabia</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Pharmaceutics</institution>, <institution>College of Pharmacy</institution>, <institution>King Saud University</institution>, <addr-line>Riyadh</addr-line>, <country>Saudi Arabia</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Chemistry</institution>, <institution>College of Science</institution>, <institution>King Saud University</institution>, <addr-line>Riyadh</addr-line>, <country>Saudi Arabia</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1130229/overview">Kumaran Subramanian</ext-link>, Sathyabama Institute of Science and Technology, India</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2099777/overview">Lakshmipathy .R</ext-link>, KCG College of Technology, India</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2184791/overview">Venkatesa Prabhu .S</ext-link>, Addis Ababa Science and Technology University, Ethiopia</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2186732/overview">Vivekanandan .B</ext-link>, Hindustan University, India</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Rabbani Syed, <email>rsyed@ksu.edu.sa</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Nanobiotechnology, a section of the journal Frontiers in Bioengineering and Biotechnology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>16</day>
<month>03</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>11</volume>
<elocation-id>1149588</elocation-id>
<history>
<date date-type="received">
<day>22</day>
<month>01</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>02</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Alangari, Mateen, Alqahtani, Shahid, Syed, Shaik, Khan, Adil and Kuniyil.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Alangari, Mateen, Alqahtani, Shahid, Syed, Shaik, Khan, Adil and Kuniyil</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>
<bold>Background</bold>: Bacterial infections and cancers may cause various acute or chronic diseases, which have become serious global health issues. This requires suitable alternatives involving novel and efficient materials to replace ineffective existing therapies. In this regard, graphene composites are being continuously explored for a variety of purposes, including biomedical applications, due to their remarkable properties.</p>
<p>
<bold>Methods:</bold> Herein, we explore, <italic>in-vitro</italic>, the different biological properties of highly reduced graphene oxide (HRG), including anti-cancer, anti-bacterial, and anti-biofilm properties. Furthermore, to analyze the interactions of graphene with proteins of microbes, <italic>in silico</italic> docking analysis was also carried out. To do this, HRG was prepared using graphene oxide as a precursor, which was further chemically reduced to obtain the final product. The as-prepared HRG was characterized using different types of microscopic and spectroscopic techniques.</p>
<p>
<bold>Results:</bold> The HRG revealed significant cytotoxic ability, using a dose-dependent anti-cell proliferation approach, which substantially killed human breast cancer cells (MCF-7) with IC<sub>50</sub> of 29.51 &#xb1; 2.68&#xa0;&#x3bc;g/mL. The HRG demonstrated efficient biological properties, i.e., even at low concentrations, HRG exhibited efficient anti-microbial properties against a variety of microorganisms. Among the different strains, Gram-positive bacteria, such as B. <italic>subtilis</italic>, MRSA, and S. <italic>aureus</italic> are more sensitive to HRG compared to Gram-negative bacteria. The bactericidal properties of HRG are almost similar to a commercially available effective antibiotic (ampicillin). To evaluate the efficacy of HRG against bacterial biofilms<italic>, Pseudomonas aeruginosa</italic> and MRSA were applied, and the results were compared with gentamycin and ampicillin, which are commonly applied standard antibiotics. Notably, HRG demonstrated high inhibition (94.23%) against <italic>P.aeruginosa</italic>, with lower MIC (50&#xa0;&#x3bc;g/mL) and IC<sub>50</sub> (26.53&#xa0;&#x3bc;g/mL) values, whereas ampicillin and gentamicin showed similar inhibition (90.45% and 91.31% respectively) but much higher MIC and IC<sub>50</sub> values.</p>
<p>
<bold>Conclusion:</bold> Therefore, these results reveal the excellent biopotential of HRG in different biomedical applications, including cancer therapy; antimicrobial activity, especially anti-biofilm activity; and other biomedicine-based therapies. Based on the molecular docking results of Binding energy, it is predicted that pelB protein and HRG would form the best stable docking complex, and high hydrogen and hydrophobic interactions between the pelB protein and HRG have been revealed. Therefore, we conclude that HRG could be used as an antibiofilm agent against P. <italic>aeruginosa</italic> infections.</p>
</abstract>
<kwd-group>
<kwd>highly reduced graphene oxide</kwd>
<kwd>antimicrobial</kwd>
<kwd>anticancer</kwd>
<kwd>
<italic>in vitro</italic>
</kwd>
<kwd>
<italic>insilco</italic>
</kwd>
</kwd-group>
<contract-sponsor id="cn001">King Saud University<named-content content-type="fundref-id">10.13039/501100002383</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Recently, graphene and its derivatives, like highly reduced graphene oxide (HRG), have become popular materials for several technological applications (<xref ref-type="bibr" rid="B22">Khan et al., 2015</xref>). In particular, due to their exceptional biological properties, the use of these materials in the field of biomedicine has been increasing continuously over the last decade (<xref ref-type="bibr" rid="B20">Khan et al., 2016</xref>). Graphene is one of the most flexible and strongest substances and has a number of other intriguing qualities, including high stability, decent biocompatibility, and excellent electrical conductivity (<xref ref-type="bibr" rid="B5">Allen, Tung, and Kaner, 2010</xref>). Due to this, different types of graphene derivatives, like single-layer graphene Nanosheets, multi-layer graphene flakes, highly oxygenated graphene (graphene oxide, GO), highly reduced graphene oxide (HRG), etc. Have been extensively applied for different biomedical applications, including drug and gene delivery, bio-imaging, tissue engineering, and cancer therapy (<xref ref-type="bibr" rid="B52">Zhu et al., 2016</xref>; <xref ref-type="bibr" rid="B31">Karki et al., 2020</xref>). In general, the biopotential of graphene derivatives is mainly dependent on the size, shape, and contents of the resulting materials (<xref ref-type="bibr" rid="B41">Skoda et al., 2014</xref>).</p>
<p>For example, in the case of pristine graphene, which only consists of a carbon network, its biological potential is highly inhibited by its low dispensability in different solvents (<xref ref-type="bibr" rid="B50">Yang et al., 2013</xref>). On the other hand, HRG exhibits decent dispensability in aqueous and other solutions due to the existence of oxygenated functional groups on its surface, which lead to the enhancement of the solubility of the resulting material (<xref ref-type="bibr" rid="B17">Jaworski et al., 2021</xref>). This results in increased acceptability of HRG for a variety of bio-medical and bio-medicinal studies. For example, HRG delivers excellent cytotoxic effects depending on the size, surface charge, and nature of oxygenated groups, which heavily contribute to the toxicity of the material (<xref ref-type="bibr" rid="B38">Sengupta et al., 2019</xref>). Therefore, in comparison to pristine graphene, HRG is more likely to produce low toxicity and decent biological potential (<xref ref-type="bibr" rid="B16">Jagie&#x142;&#x142;o et al., 2020</xref>). In addition, the preparation of pristine graphene on a large scale for biological applications is more challenging due to graphite&#x2019;s unique use as a precursor of graphene (<xref ref-type="bibr" rid="B8">Compton and Nguyen, 2010</xref>). However, the preparation of HRG is easier <italic>via</italic> chemical exfoliation approaches involving successive oxidation and the reduction of graphite, which leads to the formation of heavily oxygenated and charged graphene-like nanosheets (HRG) (<xref ref-type="bibr" rid="B2">Adil et al., 2022</xref>).</p>
<p>To date, various studies have explored the influence of graphene and its derivatives on a variety of microbes such as fungi, bacteria, cancerous cells, etc. (<xref ref-type="bibr" rid="B49">Wojtoniszak et al., 2012</xref>). However, most of the existing studies have inconsistent and inconclusive results, which is possibly attributed to different experimental conditions, types of graphene-based materials, and their preparation methods (<xref ref-type="bibr" rid="B19">Kavinkumar et al., 2017a</xref>). Thus, to utilize the full potential of graphene derivatives, different types of graphene derivatives with diverse functionalities have been extensively investigated for various biomedical applications, including treating bacterial infections and different types of cancers (<xref ref-type="bibr" rid="B39">Shafiee, Iravani, and Varma, 2022</xref>). In particular, in the case of anti-cancer activities, such as tumor therapy, graphene derivatives have received great interest, as they have so far generated diverse effects on both cancerous and normal cells (<xref ref-type="bibr" rid="B37">Rahimi et al., 2022</xref>). Furthermore, graphene-based materials are mainly comprised of carbon, which is generally considered a safe element for humans and other living organisms, and these materials have demonstrated ultimate biocompatibility (<xref ref-type="bibr" rid="B35">Pinto, Goncalves, and Magalhaes, 2013</xref>). Due to their small size and sharp edges, these materials have also been known for their easy penetration of cells, which is a prerequisite for diagnosis and other applications (<xref ref-type="bibr" rid="B43">Su et al., 2017</xref>).</p>
<p>Besides cancer, another leading cause of illness, physical impairments, and mortality worldwide is bacterial infections, which are mostly related to 33 types of bacterial species (<xref ref-type="bibr" rid="B15">Ikuta et al., 2022</xref>). Fortunately, antibiotics and other effective drugs have long protected humans from deadly bacterial infections (<xref ref-type="bibr" rid="B34">Paterson, 2019</xref>). However, extensive use of conventional antibiotics has facilitated the undesired evolution of a variety of drug-resistant bacteria, which are currently responsible for several lethal infections (<xref ref-type="bibr" rid="B32">Opal, 2016</xref>). In most cases of multi-drug resistant (MDR) infections, traditional antibacterial materials like regular antibiotics, herbal products, metal ions/oxides, quaternary ammonium compounds, and so on, have been less effective and have presented various diseases (<xref ref-type="bibr" rid="B23">Khorsandi et al., 2021</xref>; <xref ref-type="bibr" rid="B14">Huang et al., 2022</xref>). Therefore, due to the large-scale prevalence of MDR infections, scientists and medical experts have considered various non-conventional anti-bacterial substances, such as metallic and metal oxide nanoparticles, carbonaceous materials including graphene derivatives, etc., (<xref ref-type="bibr" rid="B26">MakabentaJessa Marie et al., 2021</xref>). Of these materials, graphene derivatives have so far demonstrated remarkable characteristics in combating different types of bacterial infections (<xref ref-type="bibr" rid="B44">Szunerits and Boukherroub, 2016</xref>). The toxicity of graphene derivatives against bacteria can be attributed to both physical damage and chemical interactions (<xref ref-type="bibr" rid="B18">Ji, Sun, and Qu, 2016</xref>). The physical mode of action involves the direct interactions of the sharp edges of graphene with the bacterial cell wall and/or photothermal ablation and wrapping of bacterial species, which ultimately damages them (<xref ref-type="bibr" rid="B11">Feng et al., 2019</xref>). The chemical toxicity in graphene is possibly caused by oxidative stress, which occurs due to the presence of reactive oxygen species (ROS) and charge transfer, which are largely present in graphene derivatives (<xref ref-type="bibr" rid="B51">Yaragalla, Bhavitha, and Athanassiou, 2021</xref>).</p>
<p>Furthermore, due to their small size, high specific surface area, and other unique physicochemical properties, graphene derivatives are also effective in inhibiting the formation of bacterial biofilm (<xref ref-type="bibr" rid="B6">Cao et al., 2021</xref>). Graphene-based drug delivery Nanocarriers have been known to facilitate the controlled release of antimicrobials into biofilm-infected tissues to enhance the availability and decrease the adverse side effects of antibiotics (<xref ref-type="bibr" rid="B25">Liu et al., 2021</xref>). In addition, photothermal graphene-based materials locally generate heat under the influence of light, which leads to the thermal ablation of bacteria for the photothermal therapy (PTT) of biofilm infections (<xref ref-type="bibr" rid="B48">Wang et al., 2020</xref>). Despite the fact that studies investigating the interactions between graphene derivatives with various mammalian cells to explore the regulating factors of their <italic>in vitro</italic> and <italic>in vivo</italic> toxicity are increasing at a great pace (<xref ref-type="bibr" rid="B53">Zuchowska et al., 2017</xref>), many of these studies are mainly focused on investigating the effect of graphene derivatives on selected cell cultures.</p>
<p>Thus, for a detailed exploration of the interactions of graphene derivatives with microbial and other biological entities, more comprehensive and diverse studies on different microorganisms are required. Therefore, herein, to explore the biological potential of graphene, we synthesized and oxygenated a derivative of graphene, which is referred to as highly reduced graphene oxide (HRG). The as-prepared HRG was characterized using a variety of techniques including UV, FT-IR, XRD, Raman, and TEM. The HRG is further used to investigate the antibacterial and anti-biofilm potential against a variety of bacterial strains. It has also been applied to evaluate the cytotoxic effect on MCF-7 human epithelial cells for therapeutic application in the treatment of breast cancer. All the biological experiments were performed <italic>in vitro</italic>, but to understand the interactions of HRG with the biological entities (proteins), <italic>in silico</italic> molecular docking analysis was performed.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>2 Materials and methods</title>
<sec id="s2-1">
<title>2.1 Materials</title>
<p>N2H4 (50&#x2013;60%), KMnO4 (99%), H2O2 (30&#xa0;wt%), H2SO4 (98%), and NaNO3 (99%) were procured from Sigma-Aldrich and used as such. Graphite powder (99.999%, &#x2212;200 mesh) was delivered from Alfa Aesar.</p>
</sec>
<sec id="s2-2">
<title>2.2 Preparation of graphite oxide (GRO)</title>
<p>The precursor of HRG, i.e., graphene oxide (GO) was prepared according to our previously published study, which followed a modified version of Hummers&#x2019; method (<xref ref-type="bibr" rid="B3">Al-Marri et al., 2015</xref>). Details of the preparation are presented in the supplementary information.</p>
</sec>
<sec id="s2-3">
<title>2.3 Preparation of highly reduced graphene oxide (HRG)</title>
<p>In order to prepare the highly reduced graphene oxide (HRG), freshly prepared graphene oxide suspension is transferred into a 100&#xa0;mL round bottom flask, which is fitted with a cooling condenser. The suspension was allowed to heat up to 100&#xb0;C, and subsequently, 3&#xa0;mL of hydrazine hydrate was poured with continuous stirring. Thereafter, the temperature of the reaction was slightly reduced to 98&#xa0;&#xb0;C and the stirring was continued for 24&#xa0;h. After this, the suspension was filtered, and the solid black residue was washed several times with DI water. The product was collected <italic>via</italic> centrifuge at 4,000&#xa0;rpm and dried in a vacuum.</p>
</sec>
<sec id="s2-4">
<title>2.4 Characterization techniques</title>
<p>The details of the instruments used for the characterization of the samples are presented in the supplementary information.</p>
</sec>
<sec id="s2-5">
<title>2.5 Cytotoxicity analysis</title>
<p>The cell antiproliferative analysis of HRG was conducted using MCF-7 human epithelial cells, which were obtained from the department of pharmaceutics, King Saud University. The cells were then grown in DMEM (Gibco, UK), including 1% penicillin and streptomycin in an incubator of 5% CO2 at 37&#xb0;C, with 10% fetal bovine serum (Gibco, UK) and 1% antibiotics. MCF-7 cells were exposed to HRG at different concentrations, ranging from 1.56 to 200&#xa0;&#x3bc;g/mL. After incubation for 24&#x2013;48&#xa0;h, the cell suspension was washed with PBS buffer. MTT (2,5-Diphenyl-2H-Tetrazolium Bromide) standard solution with a concentration of 5&#xa0;mg/mL was prepared, 20&#xa0;&#xb5;L of the MTT solution was added to the wells, and the plates were incubated for 4&#xa0;h at 37&#xa0;&#xb0;C. The MTT containing culture fluid was then removed, leaving the formazan crystal to precipitate. For 15&#xa0;min, the crystals were dissolved in 100&#xa0;&#xb5;L of DMSO/acetic acid/sodium lauryl sulfate (99.4 mL/0.6 mL/10&#xa0;g). The absorbance at 570&#xa0;nm was calculated using a spectrophotometric microplate reader (Synergy HT, BioTek Inst., Winooski, VT, USA). Graph Pad Prism 5.0 was used to compute the IC50 (San Diego, CA 92108, USA).</p>
</sec>
<sec id="s2-6">
<title>2.6 Screening of synthesized HRD for antimicrobial analysis</title>
<p>Antimicrobial assessment of HRG using the agar diffusion method was conducted using four pathogenic bacterial strain names. E. <italic>coli</italic>, P. <italic>auroginosa</italic>, B. <italic>subtilis</italic>, and Methicillin-resistant Staphylococcus <italic>aureus</italic> (MRSA) were collected from the Pharmaceutics Microbiology department, King Saud University. In short, bacterial cultures were subcultured and fresh cultures were prepared in Muller Hilton agar broth, and 0.5 McFarland stranded culture of each test culture was plated on MHA agar plates. Stock concentrations of HRG nanoparticles and antibiotic standard drug ampicillin were prepared, and 100&#xa0;&#xb5;L of both HRG and ampicillin were poured into wells that had been prepared on agar plates. All the test plates were prepared in triplicate and incubated for 24&#xa0;h at 37&#xb0;C. After incubation, the zone of inhibition (ZOI) diameter was measured with a scale.</p>
</sec>
<sec id="s2-7">
<title>2.7 Determination of minimum biofilm inhibitory concentration (MBIC)</title>
<p>To evaluate the HRG nanoparticles&#x2019; antibiofilm activity, a static microtiter plate assay was performed. Inoculums of 100&#xa0;&#x3bc;L of P. <italic>aeruginosa</italic> and MRSA strains were grown in polystyrene, flat-bottom 12-well microplates for 24&#xa0;h at 37&#xb0;C (Corning, NY, United States). After the supernatant was removed following incubation, the wells were then cleaned twice with normal saline sterile. Standard antibiotics, including ampicillin 1000&#xa0;&#x3bc;g/mL and gentamycin 200&#xa0;&#x3bc;g/mL, were added to the wells along with 100 &#x3bc;L of nanoparticle stock (1&#xa0;mg/mL) and antibiotics to achieve concentrations of 6.25&#x2013;1000 micrograms with the formed biofilms. After being cultured for 18&#xa0;h at 37&#xb0;C, the cells were examined using an inverted microscope (Olympus, Tokyo, Japan) set at &#xd7;40 magnification, MBIC was then recorded as the lowest concentration of nanoparticle that produced no visible growth.</p>
</sec>
<sec id="s2-8">
<title>2.8 Docking studies</title>
<p>The 2D structure of reduced graphene was sketched using the ACD/ChemSketch software and Avogadro software was used to optimize Geometry and generate a PDB file of ligand HRG. Further, the RESP charge Calculations were done using the RED Server (<ext-link ext-link-type="uri" xlink:href="https://upjv.q4md-forcefieldtools.org/REDServer-Development">https://upjv.q4md-forcefieldtools.org/REDServer-Development</ext-link>).</p>
<p>The protein sequence and the PDB file of PelB protein from P. <italic>aeruginosa</italic> PAO1 were obtained from the RCSB website (<ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/5WFT">https://www.rcsb.org/structure/5WFT</ext-link>).</p>
<p>&#x3e;5WFT_1&#x7c;Chain A&#x7c;PelB&#x7c;<italic>Pseudomonas aeruginosa</italic> (strain ATCC 15692/DSM 22644/CIP 104116/JCM 14847/LMG 12228/1C/PRS 101/PAO1) (208,964).</p>
<p>EDRTLLADLARLGEWTGNGPRALGFWKQLLAGADDPALREHAWRLSLQMFDFDSAIELLAPIGAQRQMTDEELDALVYSHETRGTPEEGEAWLRGYVQRYPKQRLAWQRLQQILEHTQ</p>
<p>We used the AutoDock 4.2 program, which uses auto dock tools to assign polar hydrogens, unified atom Kollman charges, solvation parameters, and fragmental volumes to the protein. Molecular docking procedures are frequently used to predict the binding affinities of a variety of ligands. The prepared file was saved by Auto Dock in PDBQT format. A grid map was created using Auto Grid and a grid box. A scoring grid was created using the ligand structure to speed up computation time. The grid center was set to 1.095, 1.554, and 3.894 in the x, y, and <italic>z</italic>-axes, with a grid size of 60 60 60 xyz points and a grid spacing of 0.375 A. PyMOL was used to visualize the resulting docked complex, and a subsequent docking analysis was carried out using the protein-ligand interactions (<ext-link ext-link-type="uri" xlink:href="https://plip-tool.biotec.tu-dresden.de/plip-web/plip/index">https://plip-tool.biotec.tu-dresden.de/plip-web/plip/index</ext-link>) (<xref ref-type="bibr" rid="B1">Adasme et al., 2021</xref>).</p>
</sec>
<sec id="s2-9">
<title>2.9 Statistical analyses</title>
<p>The statistical analysis for cytotoxicity and the antimicrobial assessment of HRG were analyzed using Prism software, and a <italic>p</italic>-value of 0.05 was considered statistically significant.</p>
</sec>
</sec>
<sec sec-type="results|discussion" id="s3">
<title>3 Results and discussion</title>
<sec id="s3-1">
<title>3.1 UV-Vis analysis</title>
<p>The initial confirmation of the preparation of HRG was carried out by UV analysis. Typically, GO exhibits a broad peak between 200 and 250&#xa0;nm, which shifts to a higher wavelength upon reduction. During the reduction process, the majority of oxygenated groups from the surface of graphene oxide Nanosheets are depart, leading to the restoration of aromatic conjugation (<xref ref-type="bibr" rid="B47">Vinoth et al., 2015</xref>). Similarly, in the case of HRG prepared in this study, the peak of GO appears at &#x223c;230&#xa0;nm (blue line, <xref ref-type="fig" rid="F1">Figure 1</xref>), which can be attributed to the <italic>&#x3c0;</italic>-&#x3c0;&#x2a; transition of the C&#x3d;C bond of the aromatic ring and n-&#x3c0;&#x2a; transition of C&#x3d;O bonds. However, upon reduction, the peak shifts to the higher wavelength and relocates at &#x223c;283&#xa0;nm (green line, <xref ref-type="fig" rid="F1">Figure 1</xref>), possibly indicating the reduction of GO (<xref ref-type="bibr" rid="B33">Paredes, 2008</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>UV-Vis absorption spectra of Graphite oxide (GO) and highly reduced graphene oxide (HRG).</p>
</caption>
<graphic xlink:href="fbioe-11-1149588-g001.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>3.2 FT-IR analysis</title>
<p>Due to the presence of a large number of oxygenated groups on the surface of GO, FT-IR is a suitable technique for analyzing diverse functional groups of both GO and HRG. To perform this, FT-IR spectra of both GO and HRG were measured and plotted in <xref ref-type="fig" rid="F2">Figure 2</xref>. The oxygenated groups of GO generate plenty of IR signals; the region between 1000 and 1800&#xa0;cm-1, in particular, contains a large number of peaks. The oxygenated groups of GO are comprised of diverse functional groups involving carbon and oxygen, which include carbonyl (C&#x3d;O), etheric (C-O-C), and alcoholic (C-O) functionalities. These groups generate IR signals at various frequencies, such as 1735&#xa0;cm-1 (stretching), 1400&#xa0;cm-1 (bending), 1224&#xa0;cm-1 (stretching), 1053&#xa0;cm-1 (stretching), and so on (<xref ref-type="bibr" rid="B36">RagupathyNarayanan and Pattanayak, 2014</xref>). Apart from functional groups involving carbon and oxygen, the IR signals are also generated from other functionalities involving hydroxyl groups (OH), which possibly appear as a broad peak between 3,200 and 3,500&#xa0;cm-1; in this case, it appears at 3,428 cm-1 in the FTIR spectrum of GO (blue line, <xref ref-type="fig" rid="F2">Figure 2</xref>). Usually, after the reduction of GO, the majority of these functional groups disappear, but some of them remain as it is not possible to completely remove these functional groups due to experimental constraints. Due to this, the IR signals present in GO may not completely disappear but may be present with significantly reduced intensities (<xref ref-type="bibr" rid="B45">Trivedi et al., 2015</xref>). As expected, the IR spectrum of HRG (green line, <xref ref-type="fig" rid="F2">Figure 2</xref>) exhibits similar IR peaks to that of GO, but their intensities are considerably reduced, indicating the reduction of GO. In FT-IR spectra of HRG (<xref ref-type="fig" rid="F2">Figure 2</xref>), the exclusion of such oxygen comprising groups of GO in HRG was specified by the disappearance of some of the bands in their respective FT-IR spectra, such as the bands at &#x223c;1735 and &#x223c;1630&#xa0;cm&#x2212;1. Also, the comparative intensity decrease in some of the other bands, like the decrease in intensity of the broad band at 3,440&#xa0;cm&#x2212;1 associated with the hydroxyl groups of GO, points in the direction of GO reduction.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>FT-IR spectra of Graphite oxide (GRO) and highly reduced graphene oxide (HRG).</p>
</caption>
<graphic xlink:href="fbioe-11-1149588-g002.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>3.3 XRD analysis</title>
<p>XRD analysis was performed to check the crystallinity of as-prepared HRG, and its XRD pattern was compared with other precursors, such as GO and pristine graphite. <xref ref-type="fig" rid="F3">Figure 3</xref> displays the XRD pattern of HRG (blue line), GO (green line), and graphite (red line). Since pristine graphite is highly crystalline, it exhibits a sharp characteristic peak at 26.5&#xb0; (002), with a d-spacing of 0.34&#xa0;nm, which is calculated using Bragg&#x2019;s equation (<xref ref-type="bibr" rid="B9">Divya et al., 2018</xref>). However, this changes drastically after the oxidation process, which induces severe defects in the crystalline network of graphite. Due to this, the sharp peak of graphite at 26.5&#xb0; shifts to 13.4&#xb0; (001) and appears as a broad reflection with increased interplanar distance (0.66&#xa0;nm). Additionally, the XRD spectrum of GO also displays a small shoulder peak at 42.8&#xb0;, which corresponds to (004) or (100) planes (<xref ref-type="bibr" rid="B13">Hassan et al., 2013</xref>). However, in the case of HRG, most of the functional groups are departed from GO, and the graphitic structure is partially restored; thus, the XRD reflection again shifts toward a higher angle and appears at 23.4&#xb0; (002) in their diffraction patterns indicating the formation of graphene nanosheets with a thickness of few layers. Notably, the XRD reflection of HRG is considerably broad when compared to the XRD peak of pristine graphite. This indicates the relatively low crystallinity of HRG compared to its precursor, graphite. In addition, the decreasing interplanar distance observed in HRG, with respect to GO, indicates the formation of HRG. The sp2 hybridization of the graphitic carbon is retained in HRG. As observed in <xref ref-type="fig" rid="F3">Figure 3</xref>, the diffraction peaks corresponding to graphite (2&#x3b8; &#x3d; 26.5&#xb0;) and GO (2&#x3b8; &#x3d; 13.4&#xb0;) are completely absent in the XRD pattern of HRG, which clearly points toward the formation of a crystalline intermediate, i.e., HRG.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>XRD diffractograms of Graphite oxide (GRO) and highly reduced graphene oxide (HRG).</p>
</caption>
<graphic xlink:href="fbioe-11-1149588-g003.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>3.4 Raman analysis</title>
<p>In addition, the Raman analysis of HRG was also performed, which is an efficient technique for obtaining information about the functional fragments that may appear during the chemical transformation of graphite to GO and HRG (<xref ref-type="bibr" rid="B24">Kudin et al., 2008</xref>). The Raman spectrum of HRG in <xref ref-type="fig" rid="F4">Figure 4</xref> shows two characteristic bands at 1595 and 1360&#xa0;cm-1, which correspond to the D band and G bands, respectively. In the case of pristine graphene, the in-phase vibration of the graphite lattice (G band) usually appears at 1575&#xa0;cm-1, and the disorder band caused by the graphite edges (D band) occurs at 1355&#xa0;cm-1 (data not shown here). On the other hand, the G and the D bands of GO slightly shift to a higher frequency and appear at 1592 and 1346&#xa0;cm-1 (data not shown here) (<xref ref-type="bibr" rid="B21">Khan et al., 2014</xref>). Notably, the peak locations of the G and D bands of HRG obtained in this study do not match both the reported values of pristine graphite and GO, which may indicate the formation of HRG.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Raman analysis of highly reduced graphene oxide (HRG).</p>
</caption>
<graphic xlink:href="fbioe-11-1149588-g004.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>3.5 Transmission electron microscope (TEM) analysis</title>
<p>The HRTEM analysis of HRG is shown in <xref ref-type="fig" rid="F5">Figure 5</xref> and displays the structure and layer thickness of the HRG. The obtained data show that sheets consist of a few layers stacked on top of each other, with some wrinkles and foldings. A large number of wrinkles and scrolls were noticed on the HRG surface, which constantly endured the high-energy electron beam. <xref ref-type="fig" rid="F5">Figure 5</xref> signifies an HRTEM micrograph of HRG sheets and displays the graphene lattice fringes. This provides further information about the interplanar distance of HRG material.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>HRTEM analysis of highly reduced graphene oxide (HRG).</p>
</caption>
<graphic xlink:href="fbioe-11-1149588-g005.tif"/>
</fig>
</sec>
<sec id="s3-6">
<title>3.6 Scanning electron microscope (SEM) analysis</title>
<p>The reduction of graphite oxide may induce some morphological changes from the original structure of pristine graphite and GO; these changes can be effectively observed using scanning electron microscopy. During the HRG synthesis using an oxidation-reduction approach, the layers in the graphite were exfoliated. Due to the reduction, the attained HRG has a completely different morphology. The HRG exhibited in <xref ref-type="fig" rid="F6">Figure 6</xref> has a porous structure. The SEM image in <xref ref-type="fig" rid="F6">Figure 6</xref> displays the surface morphology of HRG, which was observed as similar thin sheets aggregated randomly, with different edges, wrinkles, and scrolled surfaces.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>SEM analysis of highly reduced graphene oxide (HRG).</p>
</caption>
<graphic xlink:href="fbioe-11-1149588-g006.tif"/>
</fig>
</sec>
<sec id="s3-7">
<title>3.7 Cell proliferation assay</title>
<p>The current trends in diagnostics and therapeutics in the treatment of cancer are mainly based on nanobiotechnology, which is attracting global attention in approaching individualized treatment (<xref ref-type="bibr" rid="B7">Chaturvedi et al., 2019</xref>). The results of the MTT (4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay show that HRG has a dose-dependent anti-cell proliferation effect on MCF-7. <xref ref-type="fig" rid="F7">Figure 7</xref> illustrates the percentage cell viability of MCF-7 breast cancer cells in response to various HRG doses. At 1.56&#x2013;200&#xa0;&#x3bc;g/mL, HRG was tested for cell proliferation, and the measured IC50 for MCF-7 was 29.51 &#xb1; 2.68&#xa0;&#x3bc;g/mL at 24&#xa0;h. A recent study produced updated results showing that reduced graphene oxide nanoparticles are cytotoxic toward tested human breast MCF cell lines (<xref ref-type="bibr" rid="B42">Smina et al., 2021</xref>). Precision medicine has profited from the successful use of nanotechnology to create novel therapeutic delivery methods using nanoparticles (NPs). Advances in nanoparticle engineering have enabled the use of NPs to substantially improve efficacy while addressing heterogeneous delivery hurdles (<xref ref-type="bibr" rid="B29">Mitchell et al., 2021</xref>). A recent research study concluded that reduced graphene significant cytotoxicity with IC50 30&#xa0;&#x3bc;g/mL in tested cell lines when compared to graphene oxide (<xref ref-type="bibr" rid="B46">Varunkumar et al., 2017b</xref>).</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>MTT assay showing IC 50 value of 29&#xa0;&#x3bc;g/mL with MCF-7 cell lines incubated for 24&#xa0;h.</p>
</caption>
<graphic xlink:href="fbioe-11-1149588-g007.tif"/>
</fig>
</sec>
<sec id="s3-8">
<title>3.8 Antibacterial analysis of HRG</title>
<p>We adopted an agar diffusion assay for the assessment of susceptibility to tested pathogenic strains. Our findings are summarized in <xref ref-type="table" rid="T1">Table 1</xref>. We selected both Gram-positive and Gram-negative pathogenic strains in this study. Gram-positive bacteria such as B. <italic>subtilis</italic>, MRSA, and S. <italic>aureus</italic> exhibited susceptibility to HRG nanoparticles when compared to Gram-negative bacterial strains. Gram-negative E. <italic>coli</italic> exhibited resistance to HRG with a zone of inhibition of (21.45 &#xb1; 1.52) in comparison to standard ampicillin with a zone of inhibition of (19.16 &#xb1; 1.72) (<italic>p</italic> &#x2265; 0.05). Gram-negative P. <italic>aeruginosa s</italic>howed susceptibility to HRG with a zone of inhibition of (27.1 &#xb1; 1.17) in comparison to ampicillin, with a zone of inhibition of (20.5 &#xb1; 1.75). Gram-positive strains MRSA, S. <italic>aureus</italic>, and B. <italic>subtilis</italic> showed susceptibility to HRG with a zone of inhibition of (28.7 &#xb1; 2.21, 24.31 &#xb1; 1.98 &#x26; 24.12 &#xb1; 1.17) in comparison to ampicillin with a zone of inhibition of (21.0 &#xb1; 2.27, 19.21 &#xb1; 1.82 &#x26; 18.86 &#xb1; 1.21), respectively (<italic>p</italic> &#x2264; 0.05). A previous study found that <italic>E. coli</italic> showed resistance to reduced graph oxide nanoparticles, although it was susceptible to a high concentration of these nanoparticles (<xref ref-type="bibr" rid="B27">Mann et al., 2021</xref>). Graphene and its derivatives also show a valuable impact in tissue engineering and exhibit strict antimicrobial activities. Graphene and its derivatives are suitable candidates for creating Nano hybrid structures, which are useful in various biomedical fields like tissue differentiation, regeneration, and infection control (<xref ref-type="bibr" rid="B40">Shang et al., 2019</xref>). As a result of the indiscriminate use of antibiotics, numerous drug-resistant bacteria have emerged, necessitating the search for new antimicrobial medicines. Several unconventional materials, such as metallic and metal oxide nanoparticles, as well as carbon-based compounds, such as nanotubes and graphene, have been studied (<xref ref-type="bibr" rid="B10">Faiz et al., 2018</xref>; <xref ref-type="bibr" rid="B12">Gunawan et al., 2020</xref>). The expected mechanism of antimicrobial action of HDR may be due to both membrane and oxidation stress, as confirmed by previous studies.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>ZOI results from agar diffusion test by HRG, as compared to ampicillin. Results were presented as mean &#xb1; SD, n &#x3d; 3.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Microorganisms</th>
<th colspan="2" align="center">Zone of inhibitions (mm), mean &#xb1; SD, n &#x3d; 3</th>
</tr>
<tr>
<td align="left"/>
<td align="left">Ampicillin</td>
<td align="left">HRG</td>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">P. <italic>aeruginosa</italic>
</td>
<td align="center">20.5 &#xb1; 1.75</td>
<td align="center">27.1 &#xb1; 1.17&#x2a;&#x2a;</td>
</tr>
<tr>
<td align="center">MRSA</td>
<td align="center">21.0 &#xb1; 2.27</td>
<td align="center">28.7 &#xb1; 2.21 &#x2a;&#x2a;</td>
</tr>
<tr>
<td align="center">S<italic>. aureus</italic>
</td>
<td align="center">19.21 &#xb1; 1.82</td>
<td align="center">24.31 &#xb1; 1.98 &#x2a;</td>
</tr>
<tr>
<td align="center">E. <italic>coli</italic>
</td>
<td align="center">19.16 &#xb1; 1.72</td>
<td align="center">21.45 &#xb1; 1.52</td>
</tr>
<tr>
<td align="center">B. <italic>subtilis</italic>
</td>
<td align="center">18.86 &#xb1; 1.21</td>
<td align="center">24.12 &#xb1; 1.17 &#x2a;</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3-9">
<title>3.9 Biofilm inhibition assay</title>
<p>The anti-biofilm activity of HRG was estimated using two pathogenic strains: P.<italic>aeruginosa</italic> and MRSA, which are related to the standard antibiotics gentamicin and ampicillin, and the results are shown in <xref ref-type="table" rid="T2">Table 2</xref>. Good biofilm formation was observed to be treated with HRG, and the results were in agreement with previous studies where reduced graphene showed antibiofilm activity in tested isolates. Biofilm inhibition action of HRG against P. <italic>aeruginosa</italic> showed the highest inhibition of 94.23%, with a MIC of 50&#xa0;&#x3bc;g/mL and an IC50 of 26.53&#xa0;&#x3bc;g/mL, whereas ampicillin and gentamicin showed inhibition of 90.45% and 91.31%, with a MIC of 200&#xa0;&#x3bc;g/mL and 1000&#xa0;&#x3bc;g/mL, respectively, and the inverted microscopic results are shown in <xref ref-type="fig" rid="F8">Figure 8</xref>. The MRSA biofilm inhibition activity with HRG showed 93.76% inhibition with a MIC value of 100&#xa0;&#x3bc;g/mL and a relative IC<sub>50</sub> of 53.32&#xa0;&#x3bc;g/mL. Both ampicillin and gentamicin inhibit MRSA biofilm with higher concentrations of 200&#xa0;&#x3bc;g/mL and 250&#xa0;&#x3bc;g/mL in comparison to HRG, and concentration inverted microscopic results are included in <xref ref-type="fig" rid="F9">Figure 9</xref>. Graphene and materials made from it (GMs) showed a variety of antibacterial activities against viruses, fungi, and bacteria (<xref ref-type="bibr" rid="B4">Alangari et al., 2022</xref>). The primary source of these effects is thought to be the direct physicochemical contact between GMs and bacteria, resulting in the fatal destruction of biological components, primarily proteins, lipids, and nucleic acids (<xref ref-type="bibr" rid="B30">Mohammed et al., 2020</xref>).</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Biofilm Evaluation of MIC, Percentage inhibition, and IC50.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">S.No</th>
<th align="left">Organisms</th>
<th align="left">Drug</th>
<th align="left">MIC (&#xb5;g/mL)</th>
<th align="left">Parentage inhibition</th>
<th align="left">IC<sub>50</sub> (&#xb5;g/mL)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="3" align="left">1</td>
<td rowspan="3" align="center">
<bold>
<italic>P. aeruginosa</italic>
</bold>
</td>
<td align="center">HRG</td>
<td align="center">100</td>
<td align="center">94.23</td>
<td align="center">26.53</td>
</tr>
<tr>
<td align="center">Gentamicin</td>
<td align="center">200</td>
<td align="center">90.45</td>
<td align="center">110.55</td>
</tr>
<tr>
<td align="center">Ampicillin</td>
<td align="center">1000</td>
<td align="center">91.31</td>
<td align="center">547.58</td>
</tr>
<tr>
<td rowspan="3" align="left">2</td>
<td rowspan="3" align="center">
<bold>MRSA</bold>
</td>
<td align="center">HRG</td>
<td align="center">100</td>
<td align="center">93.76</td>
<td align="center">53.32</td>
</tr>
<tr>
<td align="center">Gentamicin</td>
<td align="center">200</td>
<td align="center">89.79</td>
<td align="center">111.37</td>
</tr>
<tr>
<td align="center">Ampicillin</td>
<td align="center">250</td>
<td align="center">91.07</td>
<td align="center">137.25</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>Results obtained using an inverted microscope (40) <bold>(A)</bold> untreated <italic>P. aeruginosa</italic> biofilm, <bold>(B)</bold> <italic>P. aeruginosa</italic> treated with HRG 100 (&#xb5;g/mL), <bold>(C)</bold> <italic>P. aeruginosa</italic> treated with HRG 200 (&#xb5;g/mL), <bold>(D)</bold> <italic>P. aeruginosa</italic> treated with Ampicillin 1&#xa0;mg/mL, and <bold>(E)</bold> <italic>P. aeruginos</italic> treated with Gentamycin (100&#xa0;mg/mL).</p>
</caption>
<graphic xlink:href="fbioe-11-1149588-g008.tif"/>
</fig>
<fig id="F9" position="float">
<label>FIGURE 9</label>
<caption>
<p>Results obtained using an inverted microscope (40) <bold>(A)</bold> untreated MRSA biofilm, <bold>(B)</bold> MRSA treated with HRG 100 (&#xb5;g/mL), <bold>(C)</bold> MRSA treated with HRG 200 (&#xb5;g/mL), <bold>(D)</bold> MRSA treated with Gentamicin 100 (&#xb5;g/mL), and <bold>(E)</bold> MRSA treated with ampicillin (1&#xa0;mg/mL).</p>
</caption>
<graphic xlink:href="fbioe-11-1149588-g009.tif"/>
</fig>
</sec>
<sec id="s3-10">
<title>3.10 Molecular docking analysis</title>
<p>Molecular docking is a powerful computational approach to investigating ligand binding to the protein molecule at the atomic level. In the present <italic>in silico</italic> studies, the PelB protein from P. <italic>aeruginosa</italic> (<xref ref-type="bibr" rid="B28">Marmont et al., 2017</xref>) was docked with the ligand-reduced graphene using AutoDock 4.2 software, and the docking results showed docking binding-free energy of 4.31&#xa0;kcal/mol and an RMSD value of 115.702 A in the high cluster docking (<xref ref-type="table" rid="T3">Table 3</xref>). Furthermore, the analysis was performed using PLIP software to analyze atomic levels of pelB protein and HRG interactions (<xref ref-type="table" rid="T4">Table 4</xref> and <xref ref-type="table" rid="T5">5</xref>; <xref ref-type="fig" rid="F10">Figure 10</xref>).</p>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>Binding energy and reference RMSD values of PelB and HRG complex.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Receptor</th>
<th align="left">Ligand binding energy</th>
<th colspan="2" align="left">Reference RMSD</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">PelB Protein</td>
<td align="left">Reduced Graphene</td>
<td align="left">4.31&#xa0;kcal/mol</td>
<td align="left">115.702 A</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T4" position="float">
<label>TABLE 4</label>
<caption>
<p>Hydrogen Bonds angle between docking complex atoms Index Residue AA Distance H-A Distance D-A Donor Angle Donor Atom Acceptor Atom.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Index</th>
<th align="left">Residue (A)</th>
<th align="left">AA</th>
<th colspan="2" align="left">Distance H-A</th>
<th align="left">Distance D-A</th>
<th align="left">Donor angle</th>
<th align="left">Donor atom</th>
<th align="left">Acceptor atom</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="right">1</td>
<td align="left">361</td>
<td align="right">TRP</td>
<td colspan="2" align="right">2.74</td>
<td align="right">3.45</td>
<td align="right">130.12</td>
<td align="left">1051 [O3]</td>
<td align="left">319 [O2]</td>
</tr>
<tr>
<td align="right">2</td>
<td align="left">377</td>
<td align="right">LEU</td>
<td colspan="2" align="right">3.55</td>
<td align="right">3.98</td>
<td align="right">108.81</td>
<td align="left">446 [Nam]</td>
<td align="left">1049 [O3]</td>
</tr>
<tr>
<td align="right">3</td>
<td align="left">378</td>
<td align="right">ALA</td>
<td colspan="2" align="right">1.83</td>
<td align="right">2.27</td>
<td align="right">102.97</td>
<td align="left">454 [Nam]</td>
<td align="left">1049 [O3]</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T5" position="float">
<label>TABLE 5</label>
<caption>
<p>Hydrophobic Interactions between ligand and receptor atoms.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Index</th>
<th align="left">Residue (A)</th>
<th align="left">AA</th>
<th align="left">Distance</th>
<th align="left">Ligand atom</th>
<th align="left">Protein atom</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="right">1</td>
<td align="left">358</td>
<td align="left">GLU</td>
<td align="right">3.1</td>
<td align="right">1037</td>
<td align="right">297</td>
</tr>
<tr>
<td align="right">2</td>
<td align="left">361</td>
<td align="left">TRP</td>
<td align="right">1.54</td>
<td align="right">1035</td>
<td align="right">329</td>
</tr>
<tr>
<td align="right">3</td>
<td align="left">361</td>
<td align="left">TRP</td>
<td align="right">1.66</td>
<td align="right">1015</td>
<td align="right">327</td>
</tr>
<tr>
<td align="right">4</td>
<td align="left">361</td>
<td align="left">TRP</td>
<td align="right">1.66</td>
<td align="right">1032</td>
<td align="right">328</td>
</tr>
<tr>
<td align="right">5</td>
<td align="left">361</td>
<td align="left">TRP</td>
<td align="right">3.38</td>
<td align="right">1012</td>
<td align="right">323</td>
</tr>
<tr>
<td align="right">6</td>
<td align="left">361</td>
<td align="left">TRP</td>
<td align="right">3.05</td>
<td align="right">1014</td>
<td align="right">326</td>
</tr>
<tr>
<td align="right">7</td>
<td align="left">362</td>
<td align="left">ARG</td>
<td align="right">3.63</td>
<td align="right">1040</td>
<td align="right">335</td>
</tr>
<tr>
<td align="right">8</td>
<td align="left">365</td>
<td align="left">LEU</td>
<td align="right">1.33</td>
<td align="right">1029</td>
<td align="right">361</td>
</tr>
<tr>
<td align="right">9</td>
<td align="left">365</td>
<td align="left">LEU</td>
<td align="right">1.02</td>
<td align="right">1025</td>
<td align="right">361</td>
</tr>
<tr>
<td align="right">10</td>
<td align="left">365</td>
<td align="left">LEU</td>
<td align="right">2.13</td>
<td align="right">1031</td>
<td align="right">359</td>
</tr>
<tr>
<td align="right">11</td>
<td align="left">365</td>
<td align="left">LEU</td>
<td align="right">1.01</td>
<td align="right">1009</td>
<td align="right">362</td>
</tr>
<tr>
<td align="right">12</td>
<td align="left">370</td>
<td align="left">PHE</td>
<td align="right">2.99</td>
<td align="right">1023</td>
<td align="right">399</td>
</tr>
<tr>
<td align="right">13</td>
<td align="left">370</td>
<td align="left">PHE</td>
<td align="right">2.33</td>
<td align="right">995</td>
<td align="right">397</td>
</tr>
<tr>
<td align="right">14</td>
<td align="left">370</td>
<td align="left">PHE</td>
<td align="right">2.76</td>
<td align="right">981</td>
<td align="right">395</td>
</tr>
<tr>
<td align="right">15</td>
<td align="left">373</td>
<td align="left">ALA</td>
<td align="right">2.29</td>
<td align="right">993</td>
<td align="right">420</td>
</tr>
<tr>
<td align="right">16</td>
<td align="left">374</td>
<td align="left">ILE</td>
<td align="right">3.99</td>
<td align="right">984</td>
<td align="right">425</td>
</tr>
<tr>
<td align="right">17</td>
<td align="left">374</td>
<td align="left">ILE</td>
<td align="right">1.11</td>
<td align="right">956</td>
<td align="right">427</td>
</tr>
<tr>
<td align="right">18</td>
<td align="left">374</td>
<td align="left">ILE</td>
<td align="right">0.97</td>
<td align="right">965</td>
<td align="right">426</td>
</tr>
<tr>
<td align="right">19</td>
<td align="left">374</td>
<td align="left">ILE</td>
<td align="right">1.39</td>
<td align="right">950</td>
<td align="right">428</td>
</tr>
<tr>
<td align="right">20</td>
<td align="left">377</td>
<td align="left">LEU</td>
<td align="right">1.19</td>
<td align="right">1012</td>
<td align="right">453</td>
</tr>
<tr>
<td align="right">21</td>
<td align="left">377</td>
<td align="left">LEU</td>
<td align="right">0.72</td>
<td align="right">999</td>
<td align="right">452</td>
</tr>
<tr>
<td align="right">22</td>
<td align="left">377</td>
<td align="left">LEU</td>
<td align="right">1.58</td>
<td align="right">987</td>
<td align="right">450</td>
</tr>
<tr>
<td align="right">23</td>
<td align="left">378</td>
<td align="left">ALA</td>
<td align="right">1.29</td>
<td align="right">958</td>
<td align="right">458</td>
</tr>
<tr>
<td align="right">24</td>
<td align="left">380</td>
<td align="left">ILE</td>
<td align="right">3.11</td>
<td align="right">1019</td>
<td align="right">473</td>
</tr>
<tr>
<td align="right">25</td>
<td align="left">380</td>
<td align="left">ILE</td>
<td align="right">1.4</td>
<td align="right">1004</td>
<td align="right">472</td>
</tr>
<tr>
<td align="right">26</td>
<td align="left">380</td>
<td align="left">ILE</td>
<td align="right">2.11</td>
<td align="right">991</td>
<td align="right">470</td>
</tr>
<tr>
<td align="right">27</td>
<td align="left">387</td>
<td align="left">THR</td>
<td align="right">2.99</td>
<td align="right">1047</td>
<td align="right">514</td>
</tr>
<tr>
<td align="right">28</td>
<td align="left">389</td>
<td align="left">GLU</td>
<td align="right">3.28</td>
<td align="right">1034</td>
<td align="right">528</td>
</tr>
<tr>
<td align="right">29</td>
<td align="left">390</td>
<td align="left">GLU</td>
<td align="right">1.16</td>
<td align="right">1027</td>
<td align="right">537</td>
</tr>
<tr>
<td align="right">30</td>
<td align="left">390</td>
<td align="left">GLU</td>
<td align="right">3.87</td>
<td align="right">1001</td>
<td align="right">536</td>
</tr>
<tr>
<td align="right">31</td>
<td align="left">393</td>
<td align="left">ALA</td>
<td align="right">1.95</td>
<td align="right">1010</td>
<td align="right">561</td>
</tr>
<tr>
<td align="right">32</td>
<td align="left">394</td>
<td align="left">LEU</td>
<td align="right">3.43</td>
<td align="right">999</td>
<td align="right">566</td>
</tr>
<tr>
<td align="right">33</td>
<td align="left">394</td>
<td align="left">LEU</td>
<td align="right">1.06</td>
<td align="right">974</td>
<td align="right">569</td>
</tr>
<tr>
<td align="right">34</td>
<td align="left">394</td>
<td align="left">LEU</td>
<td align="right">1.72</td>
<td align="right">969</td>
<td align="right">568</td>
</tr>
<tr>
<td align="right">35</td>
<td align="left">396</td>
<td align="left">TYR</td>
<td align="right">3.3</td>
<td align="right">1023</td>
<td align="right">586</td>
</tr>
<tr>
<td align="right">36</td>
<td align="left">396</td>
<td align="left">TYR</td>
<td align="right">3.51</td>
<td align="right">994</td>
<td align="right">584</td>
</tr>
<tr>
<td align="right">37</td>
<td align="left">398</td>
<td align="left">HIS</td>
<td align="right">3.76</td>
<td align="right">967</td>
<td align="right">599</td>
</tr>
<tr>
<td align="right">38</td>
<td align="left">401</td>
<td align="left">ARG</td>
<td align="right">2.16</td>
<td align="right">980</td>
<td align="right">626</td>
</tr>
<tr>
<td align="right">39</td>
<td align="left">403</td>
<td align="left">THR</td>
<td align="right">3.04</td>
<td align="right">967</td>
<td align="right">642</td>
</tr>
<tr>
<td align="right">40</td>
<td align="left">406</td>
<td align="left">GLU</td>
<td align="right">3.52</td>
<td align="right">949</td>
<td align="right">664</td>
</tr>
<tr>
<td align="right">41</td>
<td align="left">410</td>
<td align="left">TRP</td>
<td align="right">3.57</td>
<td align="right">973</td>
<td align="right">697</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="F10" position="float">
<label>FIGURE 10</label>
<caption>
<p>Hydrogen bond and hydrophobic interactions of <bold>(A)</bold> pelB protein and <bold>(B)</bold> HRG.</p>
</caption>
<graphic xlink:href="fbioe-11-1149588-g010.tif"/>
</fig>
</sec>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s4">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s9">Supplementary Material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s5">
<title>Author contributions</title>
<p>AA, AM, and RS collected, analyzed, and interpreted the data. MA and MS conducted the bioinformatics analysis. MS, MK, SA, and MK carried out the characterization and interpretation analysis. All authors conceived the original paper and provided a rough draft. AA and MA checked the paper for consistency, corrected the language, and checked the references for consistency and accuracy. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="s6">
<title>Funding</title>
<p>Researcher support unit (RSP), King Saud University, Riyadh Saudi Arabia.</p>
</sec>
<ack>
<p>The authors extend their appreciation to the Researchers Supporting Project number (RSPD2023R739), King Saud University, Riyadh, Saudi Arabia for funding this work.</p>
</ack>
<sec sec-type="COI-statement" id="s7">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s8">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s9">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbioe.2023.1149588/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fbioe.2023.1149588/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adasme</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Linnemann</surname>
<given-names>K. L.</given-names>
</name>
<name>
<surname>Bolz</surname>
<given-names>S. N.</given-names>
</name>
<name>
<surname>Kaiser</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Salentin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Joachim Haupt</surname>
<given-names>V.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Plip 2021: Expanding the scope of the protein&#x2013;ligand interaction profiler to DNA and RNA</article-title>. <source>Nucleic Acids Res.</source> <volume>49</volume> (W<issue>1</issue>), <fpage>W530</fpage>&#x2013;<lpage>W534</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkab294</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adil</surname>
<given-names>S. F.</given-names>
</name>
<name>
<surname>Ashraf</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Assal</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Rafi Shaik</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kuniyil</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Advances in graphene/inorganic nanoparticle composites for catalytic applications</article-title>. <source>Chem. Rec.</source>, <volume>22</volume>: <fpage>e202100274</fpage>.</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Marri</surname>
<given-names>A. H.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Adil</surname>
<given-names>S. F.</given-names>
</name>
<name>
<surname>Al-Warthan</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Pulicaria glutinosa extract: A toolbox to synthesize highly reduced graphene oxide-silver nanocomposites</article-title>. <source>Int. J. Mol. Sci.</source> <volume>16</volume> (<issue>1</issue>), <fpage>1131</fpage>&#x2013;<lpage>1142</lpage>. <pub-id pub-id-type="doi">10.3390/ijms16011131</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alangari</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Aldakheel</surname>
<given-names>F. M.</given-names>
</name>
<name>
<surname>Mateen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Alqhatani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Alaofi</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Shahid</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Assessment of physicochemical, anticancer, antimicrobial, and biofilm activities of N-doped graphene</article-title>. <source>Crystals</source> <volume>12</volume> (<issue>8</issue>), <fpage>1035</fpage>. <pub-id pub-id-type="doi">10.3390/cryst12081035</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allen</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Tung</surname>
<given-names>V. C.</given-names>
</name>
<name>
<surname>Kaner</surname>
<given-names>R. B.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Honeycomb carbon: A review of graphene</article-title>. <source>Chem. Rev.</source> <volume>110</volume> (<issue>1</issue>), <fpage>132</fpage>&#x2013;<lpage>145</lpage>. <pub-id pub-id-type="doi">10.1021/cr900070d</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ning</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Bi</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Antibacterial and antibiofilm properties of graphene and its derivatives</article-title>. <source>Colloids Surfaces B Biointerfaces</source> <volume>200</volume>, <fpage>111588</fpage>. <pub-id pub-id-type="doi">10.1016/j.colsurfb.2021.111588</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaturvedi</surname>
<given-names>V. K.</given-names>
</name>
<name>
<surname>Anshuman</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>V. K.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>M. P.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Cancer nanotechnology: A new revolution for cancer diagnosis and therapy</article-title>. <source>Curr. Drug Metab.</source> <volume>20</volume> (<issue>6</issue>), <fpage>416</fpage>&#x2013;<lpage>429</lpage>. <pub-id pub-id-type="doi">10.2174/1389200219666180918111528</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Compton</surname>
<given-names>O. C.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>S. T.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Graphene oxide, highly reduced graphene oxide, and graphene: Versatile building blocks for carbon&#x2010;based materials</article-title>. <source>Small</source> <volume>6</volume> (<issue>6</issue>), <fpage>711</fpage>&#x2013;<lpage>723</lpage>. <pub-id pub-id-type="doi">10.1002/smll.200901934</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Divya</surname>
<given-names>K. S.</given-names>
</name>
<name>
<surname>Chandran</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Reethu</surname>
<given-names>V. N.</given-names>
</name>
<name>
<surname>Mathew.</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Enhanced photocatalytic performance of RGO/Ag nanocomposites produced via a facile microwave irradiation for the degradation of rhodamine B in aqueous solution</article-title>. <source>Appl. Surf. Sci.</source> <volume>444</volume>, <fpage>811</fpage>&#x2013;<lpage>818</lpage>. <pub-id pub-id-type="doi">10.1016/j.apsusc.2018.01.303</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Faiz</surname>
<given-names>M. B.</given-names>
</name>
<name>
<surname>Rose</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Marquis</surname>
<given-names>C. P.</given-names>
</name>
<name>
<surname>Elizabeth</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Georgios A.</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>A. R.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Nanosilver and the microbiological activity of the particulate solids versus the leached soluble silver</article-title>. <source>Nanotoxicology</source> <volume>12</volume> (<issue>3</issue>), <fpage>263</fpage>&#x2013;<lpage>273</lpage>. <pub-id pub-id-type="doi">10.1080/17435390.2018.1434910</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Tu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Reduced graphene oxide functionalized with gold nanostar nanocomposites for synergistically killing bacteria through intrinsic antimicrobial activity and photothermal ablation</article-title>. <source>ACS Appl. Bio Mater.</source> <volume>2</volume> (<issue>2</issue>), <fpage>747</fpage>&#x2013;<lpage>756</lpage>. <pub-id pub-id-type="doi">10.1021/acsabm.8b00608</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gunawan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Faiz</surname>
<given-names>M. B.</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>R. S. T.</given-names>
</name>
<name>
<surname>Sotiriou</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Marquis</surname>
<given-names>C. P.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Nanosilver targets the bacterial cell envelope: The link with generation of reactive oxygen radicals</article-title>. <source>ACS Appl. Mater. Interfaces</source> <volume>12</volume> (<issue>5</issue>), <fpage>5557</fpage>&#x2013;<lpage>5568</lpage>. <pub-id pub-id-type="doi">10.1021/acsami.9b20193</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hassan</surname>
<given-names>Fathy M.</given-names>
</name>
<name>
<surname>Chabot</surname>
<given-names>Victor</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Jingde</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Brian Kihun</given-names>
</name>
<name>
<surname>Ricardez-Sandoval</surname>
<given-names>Luis</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Aiping</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Pyrrolic-structure enriched nitrogen doped graphene for highly efficient next generation supercapacitors</article-title>. <source>J. Mater. Chem. A</source> <volume>1</volume> (<issue>8</issue>), <fpage>2904</fpage>&#x2013;<lpage>2912</lpage>. <pub-id pub-id-type="doi">10.1039/c2ta01064j</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Targeting bacterial membrane proteins to explore the beneficial effects of natural products: New antibiotics against drug resistance</article-title>. <source>Curr. Med. Chem.</source> <volume>29</volume> (<issue>12</issue>), <fpage>2109</fpage>&#x2013;<lpage>2126</lpage>. <pub-id pub-id-type="doi">10.2174/0929867328666210614121222</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ikuta</surname>
<given-names>K. S.</given-names>
</name>
<name>
<surname>Swetschinski</surname>
<given-names>L. R.</given-names>
</name>
<name>
<surname>Aguilar</surname>
<given-names>G. R.</given-names>
</name>
<name>
<surname>Sharara</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mestrovic</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>A. P.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Global mortality associated with 33 bacterial pathogens in 2019: A systematic analysis for the global burden of disease study 2019</article-title>. <source>Lancet</source> <volume>400</volume>: <fpage>2221</fpage>&#x2013;<lpage>2248</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(22)02185-7</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jagie&#x142;&#x142;o</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Adrian</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Baran</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gwiazda</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lipi&#x144;ska</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Synthesis and characterization of graphene oxide and reduced graphene oxide composites with inorganic nanoparticles for biomedical applications</article-title>. <source>Nanomaterials</source> <volume>10</volume> (<issue>9</issue>), <fpage>1846</fpage>. <pub-id pub-id-type="doi">10.3390/nano10091846</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jaworski</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Strojny-Cie&#x15b;lak</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wierzbicki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kutwin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sawosz</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kamaszewski</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Comparison of the toxicity of pristine graphene and graphene oxide, using four biological models</article-title>. <source>Materials</source> <volume>14</volume> (<issue>15</issue>), <fpage>4250</fpage>. <pub-id pub-id-type="doi">10.3390/ma14154250</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ji</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Antibacterial applications of graphene-based nanomaterials: Recent achievements and challenges</article-title>. <source>Adv. Drug Deliv. Rev.</source> <volume>105</volume>, <fpage>176</fpage>&#x2013;<lpage>189</lpage>. <pub-id pub-id-type="doi">10.1016/j.addr.2016.04.009</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kavinkumar</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Varunkumar</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ravikumar</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Manivannan</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2017a</year>). <article-title>Anticancer activity of graphene oxide-reduced graphene oxide-silver nanoparticle composites</article-title>. <source>J. Colloid Interface Sci.</source> <volume>505</volume>, <fpage>1125</fpage>&#x2013;<lpage>1133</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcis.2017.07.002</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>AbdulhadiAl-Marri</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Al-Warthan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Alkhathlan</surname>
<given-names>H. Z.</given-names>
</name>
<name>
<surname>Siddiqui</surname>
<given-names>M. R. H.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Apoptosis inducing ability of silver decorated highly reduced graphene oxide nanocomposites in A549 lung cancer</article-title>. <source>Int. J. Nanomedicine</source> <volume>11</volume>, <fpage>873</fpage>&#x2013;<lpage>883</lpage>. <pub-id pub-id-type="doi">10.2147/ijn.s100903</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Al-Marri</surname>
<given-names>A. H.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mohri</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Adil</surname>
<given-names>S. F.</given-names>
</name>
<name>
<surname>Al-Warthan</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Pulicaria glutinosa plant extract: A green and eco-friendly reducing agent for the preparation of highly reduced graphene oxide</article-title>. <source>RSC Adv.</source> <volume>4</volume> (<issue>46</issue>), <fpage>24119</fpage>&#x2013;<lpage>24125</lpage>. <pub-id pub-id-type="doi">10.1039/c4ra01296h</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tahir</surname>
<given-names>M. N.</given-names>
</name>
<name>
<surname>Adil</surname>
<given-names>S. F.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>H. U.</given-names>
</name>
<name>
<surname>Siddiqui</surname>
<given-names>M. R. H.</given-names>
</name>
<name>
<surname>Al-warthan</surname>
<given-names>A. A.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Graphene based metal and metal oxide nanocomposites: Synthesis, properties and their applications</article-title>. <source>J. Mater. Chem. A</source> <volume>3</volume> (<issue>37</issue>), <fpage>18753</fpage>&#x2013;<lpage>18808</lpage>. <pub-id pub-id-type="doi">10.1039/c5ta02240a</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khorsandi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Keyvani-Ghamsari</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shahidi</surname>
<given-names>F. K.</given-names>
</name>
<name>
<surname>Hosseinzadeh</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kanwal</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>A mechanistic perspective on targeting bacterial drug resistance with nanoparticles</article-title>. <source>J. Drug Target.</source> <volume>29</volume> (<issue>9</issue>), <fpage>941</fpage>&#x2013;<lpage>959</lpage>. <pub-id pub-id-type="doi">10.1080/1061186x.2021.1895818</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kudin</surname>
<given-names>K. N.</given-names>
</name>
<name>
<surname>Ozbas</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Schniepp</surname>
<given-names>H. C.</given-names>
</name>
<name>
<surname>Robert</surname>
<given-names>K. P.</given-names>
</name>
<name>
<surname>Ilhan</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Car</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Raman spectra of graphite oxide and functionalized graphene sheets</article-title>. <source>Nano Lett.</source> <volume>8</volume> (<issue>1</issue>), <fpage>36</fpage>&#x2013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1021/nl071822y</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Controlled drug delivery systems in eradicating bacterial biofilm-associated infections</article-title>. <source>J. Control. Release</source> <volume>329</volume>, <fpage>1102</fpage>&#x2013;<lpage>1116</lpage>. <pub-id pub-id-type="doi">10.1016/j.jconrel.2020.10.038</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Makabenta Jessa Marie</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.-H.</given-names>
</name>
<name>
<surname>Schmidt-Malan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>Robin</given-names>
</name>
<name>
<surname>VincentRotello</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>19</volume> (<issue>1</issue>), <fpage>23</fpage>&#x2013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1038/s41579-020-0420-1</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mann</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mitsidis</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>McNeilly</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>Y. H.</given-names>
</name>
<name>
<surname>Amal</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Antibacterial activity of reduced graphene oxide</article-title>. <source>J. Nanomater.</source> <volume>2021</volume>, <fpage>1</fpage>&#x2013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1155/2021/9941577</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marmont</surname>
<given-names>L. S.</given-names>
</name>
<name>
<surname>Whitfield</surname>
<given-names>G. B.</given-names>
</name>
<name>
<surname>Rich</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Yip</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Giesbrecht</surname>
<given-names>L. B.</given-names>
</name>
<name>
<surname>Stremick</surname>
<given-names>C. A.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>PelA and PelB proteins form a modification and secretion complex essential for pel polysaccharide-dependent biofilm formation in Pseudomonas aeruginosa</article-title>. <source>J. Biol. Chem.</source> <volume>292</volume> (<issue>47</issue>), <fpage>19411</fpage>&#x2013;<lpage>19422</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m117.812842</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mitchell</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Billingsley</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Haley</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Wechsler</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Peppas</surname>
<given-names>N. A.</given-names>
</name>
<name>
<surname>Langer</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Engineering precision nanoparticles for drug delivery</article-title>. <source>Nat. Rev. Drug Discov.</source> <volume>20</volume> (<issue>2</issue>), <fpage>101</fpage>&#x2013;<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1038/s41573-020-0090-8</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohammed</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Elena</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Al-Hadeethi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Antimicrobial mechanisms and effectiveness of graphene and graphene-functionalized biomaterials. A scope review</article-title>. <source>Front. Bioeng. Biotechnol.</source> <volume>8</volume>, <fpage>465</fpage>. <pub-id pub-id-type="doi">10.3389/fbioe.2020.00465</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neha</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tiwari</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tewari</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rana</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pandey</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Basak</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Functionalized graphene oxide as a vehicle for targeted drug delivery and bioimaging applications</article-title>. <source>J. Mater. Chem. B</source> <volume>8</volume> (<issue>36</issue>), <fpage>8116</fpage>&#x2013;<lpage>8148</lpage>. <pub-id pub-id-type="doi">10.1039/d0tb01149e</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Opal</surname>
<given-names>S. M.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Non-antibiotic treatments for bacterial diseases in an era of progressive antibiotic resistance</article-title>. <source>Crit. Care</source> <volume>20</volume>, <fpage>397</fpage>. <pub-id pub-id-type="doi">10.1186/s13054-016-1549-1</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paredes</surname>
<given-names>J. I.</given-names>
</name>
<name>
<surname>Villar-Rodil</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Martinez-Alonso</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tascon</surname>
<given-names>J. M. D.</given-names>
</name>
<name>
<surname>Silvia</surname>
<given-names>V.-R.</given-names>
</name>
<name>
<surname>Amelia</surname>
<given-names>M.-A.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>Graphene oxide dispersions in organic solvents</article-title>. <source>Langmuir</source> <volume>24</volume> (<issue>19</issue>), <fpage>10560</fpage>&#x2013;<lpage>10564</lpage>. <pub-id pub-id-type="doi">10.1021/la801744a</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Paterson</surname>
<given-names>I. K.</given-names>
</name>
</person-group> (<year>2019</year>). <source>The fight against antimicrobial resistance: Optimising antibiotic usage to treat bacterial infections</source>. <publisher-loc>Stirling, Scotland</publisher-loc>: <publisher-name>University of Stirling</publisher-name>.</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinto</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Goncalves</surname>
<given-names>I. C.</given-names>
</name>
<name>
<surname>Magalhaes</surname>
<given-names>F. D.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Graphene-based materials biocompatibility: A review</article-title>. <source>Colloids Surfaces B Biointerfaces</source> <volume>111</volume>, <fpage>188</fpage>&#x2013;<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1016/j.colsurfb.2013.05.022</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Praveen</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Kesavan</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kalita</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ragupathy</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Narayanan</surname>
<given-names>T. N.</given-names>
</name>
<name>
<surname>Pattanayak</surname>
<given-names>D. K.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>On the large capacitance of nitrogen doped graphene derived by a facile route</article-title>. <source>RSC Adv.</source> <volume>4</volume> (<issue>73</issue>), <fpage>38689</fpage>&#x2013;<lpage>38697</lpage>. <pub-id pub-id-type="doi">10.1039/c4ra04927f</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rahimi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zareian</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pandit</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mijakovic</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Cellular and subcellular interactions of graphene-based materials with cancerous and non-cancerous cells</article-title>. <source>Adv. Drug Deliv. Rev.</source>, <volume>189</volume>: <fpage>114467</fpage>, <pub-id pub-id-type="doi">10.1016/j.addr.2022.114467</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sengupta</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Bhattacharya</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Talukdar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Neogi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pal</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Chakraborty</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Bactericidal effect of graphene oxide and reduced graphene oxide: Influence of shape of bacteria</article-title>. <source>Colloid Interface Sci. Commun.</source> <volume>28</volume>, <fpage>60</fpage>&#x2013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1016/j.colcom.2018.12.001</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shafiee</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Iravani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>RajenderVarma</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Graphene and graphene oxide with anticancer applications: Challenges and future perspectives</article-title>. <source>MedComm</source> <volume>3</volume> (<issue>1</issue>), <fpage>e118</fpage>. <pub-id pub-id-type="doi">10.1002/mco2.118</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Shang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Qi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Pei</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <source>Theranostic bionanomaterials</source>. <publisher-loc>Amsterdam, Netherlands</publisher-loc>: <publisher-name>Elsevier</publisher-name>.</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skoda</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ilona</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Anna</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dariusz</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Graphene: One material, many possibilities&#x2014;application difficulties in biological systems</article-title>. <source>J. Nanomater.</source> <volume>2014</volume>.</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smina</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Lalitha</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Nagabhushana</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Screening of anti-cancer activity of reduced graphene oxide biogenically synthesized against human breast cancer MCF-7 cell lines</article-title>. <source>Appl. Nanosci.</source> <volume>11</volume> (<issue>4</issue>), <fpage>1093</fpage>&#x2013;<lpage>1105</lpage>. <pub-id pub-id-type="doi">10.1007/s13204-021-01696-9</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su</surname>
<given-names>Y.-L.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>T.-W.</given-names>
</name>
<name>
<surname>Chiang</surname>
<given-names>W.-H.</given-names>
</name>
<name>
<surname>Chiu</surname>
<given-names>H.-C.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>C.-H.</given-names>
</name>
<name>
<surname>Chiang</surname>
<given-names>C.-S.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Hierarchically targeted and penetrated delivery of drugs to tumors by size&#x2010;changeable graphene quantum dot nanoaircrafts for photolytic therapy</article-title>. <source>Adv. Funct. Mater.</source> <volume>27</volume> (<issue>23</issue>), <fpage>1700056</fpage>. <pub-id pub-id-type="doi">10.1002/adfm.201700056</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szunerits</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Boukherroub</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Antibacterial activity of graphene-based materials</article-title>. <source>J. Mater. Chem. B</source> <volume>4</volume> (<issue>43</issue>), <fpage>6892</fpage>&#x2013;<lpage>6912</lpage>. <pub-id pub-id-type="doi">10.1039/c6tb01647b</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trivedi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Branton</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Trivedi</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Shettigar</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bairwa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Jana</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Fourier transform infrared and ultraviolet-visible spectroscopic characterization of biofield treated salicylic acid and sparfloxacin</article-title>. <source>Nat. Prod. Chem. Res.</source> <volume>5</volume> (<issue>3</issue>). <pub-id pub-id-type="doi">10.4172/2329-6836.1000186</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varunkumar</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ravikumar</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Manivannan</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2017b</year>). <article-title>Anticancer activity of graphene oxide-reduced graphene oxide-silver nanoparticle composites</article-title>. <source>J. Colloid Interface Sci.</source> <volume>505</volume>, <fpage>1125</fpage>&#x2013;<lpage>1133</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcis.2017.07.002</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vinoth</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ganesh Babu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bahnemann</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Neppolian</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Nitrogen doped reduced graphene oxide hybrid metal free catalyst for effective reduction of 4-nitrophenol</article-title>. <source>Sci. Adv. Mater.</source> <volume>7</volume> (<issue>7</issue>), <fpage>1443</fpage>&#x2013;<lpage>1449</lpage>. <pub-id pub-id-type="doi">10.1166/sam.2015.2181</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>He</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>A dual-targeted platform based on graphene for synergistic chemo-photothermal therapy against multidrug-resistant gram-negative bacteria and their biofilms</article-title>. <source>Chem. Eng. J.</source> <volume>393</volume>, <fpage>124595</fpage>. <pub-id pub-id-type="doi">10.1016/j.cej.2020.124595</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wojtoniszak</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Kalenczuk</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Anna</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>&#x141;apczuk</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kurzewski</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Synthesis, dispersion, and cytocompatibility of graphene oxide and reduced graphene oxide</article-title>. <source>Colloids Surfaces B Biointerfaces</source> <volume>89</volume>, <fpage>79</fpage>&#x2013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1016/j.colsurfb.2011.08.026</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Behavior and toxicity of graphene and its functionalized derivatives in biological systems</article-title>. <source>Small</source> <volume>9</volume> (<issue>9&#x2010;10</issue>), <fpage>1492</fpage>&#x2013;<lpage>1503</lpage>. <pub-id pub-id-type="doi">10.1002/smll.201201417</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yaragalla</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Karanath</surname>
<given-names>B. B.</given-names>
</name>
<name>
<surname>Athanassia</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>A review on graphene based materials and their antimicrobial properties</article-title>. <source>Coatings</source> <volume>11</volume> (<issue>10</issue>), <fpage>1197</fpage>. <pub-id pub-id-type="doi">10.3390/coatings11101197</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pei</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Applications of graphene and its derivatives in intracellular biosensing and bioimaging</article-title>. <source>Analyst</source> <volume>141</volume> (<issue>15</issue>), <fpage>4541</fpage>&#x2013;<lpage>4553</lpage>. <pub-id pub-id-type="doi">10.1039/c6an01090c</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zuchowska</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chudy</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dybko</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Brzozka</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Graphene as a new material in anticancer therapy-<italic>in vitro</italic> studies</article-title>. <source>Sensors Actuators B Chem.</source> <volume>243</volume>, <fpage>152</fpage>&#x2013;<lpage>165</lpage>. <pub-id pub-id-type="doi">10.1016/j.snb.2016.11.105</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>